IMC Chicago
EDIT icon

IMC Chicago’s Editas Medicine EDIT Stock Holding History

IMC Chicago’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
+42,500
New +$89.9K ﹤0.01% 5315
2023
Q1 		– Sell
-52,700
Closed -$467K – 1299
2022
Q4 		$467K Sell
52,700
-50,800
-49% -$558K ﹤0.01% 1149
2022
Q3 		$1.27M Sell
103,500
-15,600
-13% -$243K ﹤0.01% 867
2022
Q2 		$1.41M Sell
119,100
-300
-0.3% -$4.02K ﹤0.01% 765
2022
Q1 		$2.27M Buy
119,400
+5,500
+5% +$102K ﹤0.01% 749
2021
Q4 		$3.02M Sell
113,900
-115,600
-50% -$3.98M ﹤0.01% 719
2021
Q3 		$9.43M Buy
229,500
+142,900
+165% +$7.83M 0.01% 498
2021
Q2 		$4.91M Buy
86,600
+44,600
+106% +$1.65M 0.01% 594
2021
Q1 		$1.76M Buy
+42,000
New +$2.39M ﹤0.01% 759

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IMC Chicago's EDIT Position: Q1 2023 in Review

IMC Chicago sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 34,094 shares — an estimated $303K sold.

IMC Chicago first reported a position in EDIT in Q3 2021 and held it in 6 quarters. The position peaked at $1.43M in Q1 2022. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • IMC Chicago reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • IMC Chicago sold 34,094 Editas Medicine shares in Q1 2023, an estimated $303K.
  • IMC Chicago first reported a position in Editas Medicine in Q3 2021 and held it in 6 quarters.
  • IMC Chicago's Editas Medicine position peaked at $1.43M in Q1 2022.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on IMC Chicago's 13F filing for Q1 2023, filed 24 Apr 2023.